Shreeram Proteins Ltd
NSE:SRPL
Balance Sheet
Balance Sheet Decomposition
Shreeram Proteins Ltd
Shreeram Proteins Ltd
Balance Sheet
Shreeram Proteins Ltd
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
11
|
13
|
3
|
3
|
1
|
4
|
7
|
8
|
10
|
313
|
0
|
1
|
0
|
|
| Cash Equivalents |
11
|
13
|
3
|
3
|
1
|
4
|
7
|
8
|
10
|
313
|
0
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
95
|
191
|
592
|
383
|
387
|
544
|
373
|
514
|
434
|
80
|
281
|
237
|
236
|
|
| Accounts Receivables |
47
|
177
|
581
|
372
|
379
|
527
|
369
|
513
|
434
|
80
|
278
|
237
|
236
|
|
| Other Receivables |
47
|
14
|
11
|
11
|
8
|
17
|
4
|
1
|
0
|
0
|
3
|
0
|
0
|
|
| Inventory |
233
|
303
|
294
|
319
|
370
|
466
|
472
|
388
|
471
|
626
|
389
|
359
|
173
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
15
|
12
|
10
|
72
|
318
|
323
|
322
|
|
| Total Current Assets |
338
|
508
|
889
|
705
|
758
|
1 014
|
867
|
921
|
925
|
1 091
|
988
|
920
|
732
|
|
| PP&E Net |
199
|
171
|
149
|
130
|
115
|
106
|
96
|
84
|
74
|
68
|
70
|
56
|
49
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
70
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
195
|
0
|
0
|
|
| Note Receivable |
1
|
45
|
1
|
1
|
1
|
1
|
3
|
3
|
2
|
2
|
2
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
3
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
7
|
6
|
|
| Total Assets |
538
N/A
|
723
+34%
|
1 040
+44%
|
839
-19%
|
874
+4%
|
1 126
+29%
|
966
-14%
|
1 008
+4%
|
1 001
-1%
|
1 161
+16%
|
1 061
-9%
|
983
-7%
|
787
-20%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
32
|
5
|
286
|
134
|
201
|
228
|
105
|
141
|
91
|
186
|
82
|
97
|
103
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
258
|
314
|
250
|
312
|
313
|
293
|
313
|
297
|
308
|
300
|
269
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
10
|
21
|
23
|
267
|
248
|
|
| Other Current Liabilities |
0
|
24
|
105
|
18
|
14
|
32
|
9
|
15
|
9
|
24
|
46
|
50
|
47
|
|
| Total Current Liabilities |
290
|
343
|
641
|
464
|
527
|
553
|
430
|
453
|
417
|
531
|
421
|
414
|
398
|
|
| Long-Term Debt |
177
|
298
|
304
|
187
|
160
|
169
|
104
|
98
|
120
|
105
|
78
|
103
|
133
|
|
| Deferred Income Tax |
2
|
1
|
0
|
0
|
8
|
8
|
6
|
5
|
3
|
2
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
470
N/A
|
642
+37%
|
945
+47%
|
651
-31%
|
696
+7%
|
730
+5%
|
539
-26%
|
556
+3%
|
540
-3%
|
638
+18%
|
500
-22%
|
518
+4%
|
532
+3%
|
|
| Equity | ||||||||||||||
| Common Stock |
63
|
63
|
63
|
150
|
150
|
214
|
214
|
214
|
214
|
214
|
214
|
214
|
214
|
|
| Retained Earnings |
6
|
19
|
33
|
38
|
28
|
181
|
212
|
238
|
247
|
308
|
212
|
251
|
41
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
135
|
0
|
0
|
|
| Total Equity |
69
N/A
|
82
+19%
|
95
+17%
|
188
+97%
|
178
-5%
|
396
+122%
|
426
+8%
|
452
+6%
|
461
+2%
|
522
+13%
|
561
+7%
|
465
-17%
|
255
-45%
|
|
| Total Liabilities & Equity |
538
N/A
|
723
+34%
|
1 040
+44%
|
839
-19%
|
874
+4%
|
1 126
+29%
|
966
-14%
|
1 008
+4%
|
1 001
-1%
|
1 161
+16%
|
1 061
-9%
|
983
-7%
|
787
-20%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
15
|
15
|
15
|
15
|
15
|
21
|
21
|
21
|
21
|
21
|
257
|
428
|
428
|
|